N. Clumeck

Virological response with fully active etravirine: pooled results from the DUET-1 and DUET-2 trials

J. Vingerhoets, S. Nijs, Jean-Michel Molina, 2010, International journal of STD & AIDS.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy

N. Clumeck, S. De Wit, O. Vandenberg, 2017, Epidemiology and Infection.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.

R. Schooley, R. Haubrich, D. Richman, 1999, AIDS.

Week 96 analysis of rilpivirine or efavirenz in HIV‐1‐infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double‐blind trials

C. Orkin, N. Clumeck, J. Molina, 2014, HIV medicine.